Literature DB >> 23869620

Role of glutamate receptors in the dorsal reticular nucleus in formalin-induced secondary allodynia.

Mónica Ambriz-Tututi1, Marcela Palomero-Rivero2, Fernanda Ramirez-López2, Diana Millán-Aldaco2, And René Drucker-Colín2.   

Abstract

The role of glutamate receptors present in the medullary dorsal reticular nucleus (DRt) in the formalin test and formalin-induced secondary nociception was studied in rats. Secondary mechanical allodynia was assessed with von Frey filaments applied to the rat's hindpaw, and secondary thermal hyperalgesia was evaluated with the tail-immersion test. The selective glutamate receptor antagonists MK801 (N-methyl-D-aspartate receptor antagonist), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (AMPA/KA receptor antagonist) and A841720 (metabotropic glutamate 1 receptor antagonist) were injected into the DRt before or 6 days after formalin injection in the rat. In the formalin test, the three antagonists significantly reduced the number of flinches in both phases of the test. DRt microinjection of MK801 or A841720, but not of CNQX, reduced both secondary nociceptive behaviors. Moreover, pre-treatment with the three antagonists injected into the DRt prevented the development of secondary mechanical allodynia and secondary thermal hyperalgesia. Similarly, in these rats, the number of c-Fos-like immunoreactive neurons were markedly reduced in both the superficial and deep lamina of the dorsal horn. Our findings support the role of DRt as a pain facilitator in acute and chronic pain states, and suggest a key role of glutamate receptors during the development and maintenance of formalin-induced secondary allodynia.
© 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  descending facilitation; dorsal reticular nucleus; glutamate receptors; rat; secondary allodynia

Mesh:

Substances:

Year:  2013        PMID: 23869620     DOI: 10.1111/ejn.12302

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  5 in total

1.  Sleep-wake cycle disturbances and NeuN-altered expression in adult rats after cannabidiol treatments during adolescence.

Authors:  Eric Murillo-Rodríguez; Diana Millán-Aldaco; Dorotea Cicconcelli; Valentina Giorgetti; Gloria Arankowsky-Sandoval; Jocelyne Alcaraz-Silva; Claudio Imperatori; Sérgio Machado; Henning Budde; Pablo Torterolo
Journal:  Psychopharmacology (Berl)       Date:  2021-02-26       Impact factor: 4.530

2.  Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: The role of TLR4 in the evolution of a persistent pain state.

Authors:  Sarah A Woller; Satheesh B Ravula; Fabio C Tucci; Graham Beaton; Maripat Corr; R Rivkah Isseroff; Athena M Soulika; Marianne Chigbrow; Kelly A Eddinger; Tony L Yaksh
Journal:  Brain Behav Immun       Date:  2016-04-01       Impact factor: 7.217

3.  Essential role of endogenous calcitonin gene-related peptide in pain-associated plasticity in the central amygdala.

Authors:  Kei Shinohara; Ayako M Watabe; Masashi Nagase; Yuya Okutsu; Yukari Takahashi; Hiroki Kurihara; Fusao Kato
Journal:  Eur J Neurosci       Date:  2017-09-07       Impact factor: 3.386

Review 4.  Reticular Formation and Pain: The Past and the Future.

Authors:  Isabel Martins; Isaura Tavares
Journal:  Front Neuroanat       Date:  2017-07-05       Impact factor: 3.856

5.  Analgesic Effects of Duloxetine on Formalin-Induced Hyperalgesia and Its Underlying Mechanisms in the CeA.

Authors:  Lie Zhang; Jun-Bin Yin; Wei Hu; Wen-Jun Zhao; Qing-Rong Fan; Zhi-Chun Qiu; Ming-Jie He; Tan Ding; Yan Sun; Alan D Kaye; En-Ren Wang
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.